Tanzania Medical Device Registration versus Notification: Routes, Criteria and Validity
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Marketing authorization in Tanzania offers only two routes: registration and notification. The dividing line is drawn by Part I §3.2 of the June 2024 Compendium:
- Registration: applies to all Class B, C and D devices and IVDs, and to Class A devices possessing any one of the following characteristics:
- a) Active devices
- b) Measuring function
- c) Sterile
- Notification: reserved for Class A devices and IVDs that do not meet the registration criteria.
Two consequences follow directly. First, registration certificates are valid for 5 years and notification approvals for 3 years (Part I §5.1). Second, a notification application undergoes first assessment only, with a processing time of 5 working days (Part I §3.4.8), whereas registration runs through all four stages of scheduling, assessment, quality assurance and administrative processing. The two routes therefore differ not only in dossier depth but in validity period, review structure and total elapsed time, and choosing between them is a strategic decision rather than a paperwork choice.
2. Legal basis
| Instrument | Number | Publication date | Provisions |
|---|---|---|---|
| Compendium of Guidelines for Marketing Authorization of Medical Devices, Diagnostics and Laboratory Equipment | No gazette number (TMDA guidance document) | June 2024 | Part I §3.2 (Routes for Marketing Authorization), §3.4.8, §5.1; opening paragraph of Part II |
| The Tanzania Food, Drugs and Cosmetics (Control of Medical Devices) Regulations, 2015 | GN. No. 315 | 31 July 2015 | Sections 5(1), 13(1), 13(2), 17(1) |
| The Tanzania Medicines and Medical Devices (Fees and Charges) Regulations, 2022 | Fees Regulations (2022) | 2022 | Fee tables for devices and IVDs (Notification / Registration rows) |
3. Expert insights
Insight 1: The official wording uses “and” in two places, but the practical meaning is that satisfying any single characteristic requires registration.
Part I §3.2 reads: select class A devices that possess the following characteristics: a) Active devices; b) Measuring function; and c) Sterile — using “and”. The opening paragraph of Part II, however, states that the notification route is “not applicable for class A medical devices supplied in non-sterile state, non-active and non-measuring function. Such devices are exempted from registration”. Read together, the exemption requires all three characteristics to be absent simultaneously (non-sterile + non-active + no measuring function), which reversed means satisfying any one of them requires registration. GRZAN recommends operating on the any-one-means-register reading — a submission on the looser reading is rejected and returned at the §3.4.2 screening step for applying under the wrong product class.
Insight 2: This is the most visible institutional difference between Tanzania and Kenya.
Kenya’s PPB applies listing to Class A devices with a set of nine documents; Tanzania’s notification is not only gated by three technical characteristics, but its approval is valid for only 3 years, and the notification route is extended to veterinary devices, laboratory equipment and medical gases (see article 06). Transplanting Kenyan listing experience directly into Tanzania produces errors in validity planning, dossier structure and product scope. Each market must be worked from its own guidance documents.
Insight 3: The 3-year versus 5-year split directly reshapes renewal scheduling and annual retention fee rhythm.
Part I §5.1 states expressly: registration is valid for 5 years and notification approval for 3 years, unless suspended or cancelled by TMDA or terminated by the authorization holder. The validity of both is simultaneously subject to three conditions: a) payment of the annual retention fee under the current fees regulations; b) submission of PMS reports; and c) submission of reports on undesirable effects related to the use of the device. A notification holder that plans renewals on a 5-year cycle will find the approval expired in year 3, with the device back under the Section 6 prohibition in the interval.
Insight 4: Notification is not a simplified registration; the dossier structure is different.
The notification technical requirements in Part IV and the registration technical requirements in Part II are not the same set. Notification requires: a product description covering 5 items; photographs of the commercial packaging with all faces clearly visible; mock-ups of the primary and secondary packaging labels; copies of the IFU, user manual and package insert; the manufacturer’s ISO 13485 certificate (issued by a recognized conformity assessment body, CAB); a Declaration of Conformity (DoC) addressed to TMDA, completed per Annex I of the Compendium and signed and stamped by the manufacturer; the device specifications and a list of applicable standards; and samples. It does not require a full STED.
4. Practical recommendations
- Run the three-characteristic screening first for every Class A product: does it contain a power source or driving energy? Is it used for measurement? Is it supplied sterile? Any “yes” means preparing for registration.
- Do not choose notification to save fees. Notification fees are indeed lower (USD 100 for import versus USD 500 for Class A registration), but a wrong selection is rejected and returned, and the 1–2 working-day issue time at screening is wasted.
- Set the renewal cycle for notification holders at 3 years, and start at least 90 days before expiry (Section 17(4) of GN 315).
- The DoC must use the Annex I template of the Compendium, completed, signed and stamped by the manufacturer; a self-drafted version is not accepted.
5. Verification checklist
- □ The three-characteristic screening (active / measuring function / sterile) is complete with the determination on record.
- □ Operation on the reading that satisfying any one characteristic requires registration has been confirmed.
- □ Validity periods confirmed: 5 years for registration, 3 years for notification.
- □ The notification document list has been confirmed different from the registration document list.
- □ The DoC uses the Annex I template of the Compendium and is signed and stamped by the manufacturer.
Regulatory information verified as of 29 October 2026. All provisions cited in this article were checked against the texts officially published by TMDA (June 2024 Compendium Part I §3.2 / §3.4.8 / §5.1, Part II, Part IV; GN. No. 315 Sections 13 and 17); the content is re-reviewed whenever the regulations are updated.
- Local resources in Tanzania: GRZAN can coordinate licensed local responsible persons (LRP) and distributor resources covering online submission, sample delivery, quality audit support and port clearance.
- Service capabilities: classification determination, route selection between registration and notification, technical documentation (CSDT/STED) preparation and localization, GMDN coding and grouping strategy, clinical evidence organization, software and AI device submissions, change management, vigilance and PMS reporting, annual retention fees and renewal management.
- Contact: hito.lin@grzan.cn; website www.grzan.cn.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us